A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
Conditions: Anatomic Stage IV Breast Cancer AJCC v8; Invasive Breast Carcinoma; Metastatic Breast Adenocarcinoma; Prognostic Stage IV Breast Cancer AJCC v8; Recurrent Breast Carcinoma Intervention: Biological: Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein Sponsors: Mayo Clinic; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Cancer Vaccines | Carcinoma | Helicobacter Pylori | Measles | Measles Vaccine | Research | Vaccines